Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Reducing travel-related SARS-CoV-2 transmission with layered mitigation measures: symptom monitoring, quarantine, and testing

Fig. 4

Reductions in SARS-CoV-2 transmission risk from infected travelers post-arrival. Reduction in transmission risk after arrival assuming a 7-day exposure window prior to arrival, stratified by day of test and symptom monitoring, with and without a 7-day quarantine. Symptom monitoring is assumed to be ongoing before, during, and after travel and either symptom onset or a positive test result is assumed to result in immediate isolation until the individual is no longer infectious

Back to article page